National Institute on Drug Abuse- 2023-2024
Higher buprenorphine doses associated with improved retention in treatment for opioid use disorder
Marijuana and hallucinogen use, binge drinking reached historic highs among adults 35 to 50
Only 1 in 5 U.S. adults with opioid use disorder received medications to treat it in 2021
Xylazine appears to worsen the life-threatening effects of opioids in rats